Abiopharma

News list

📋 STUELPNAGEL JOHN R (Director) plans to sell 20K shares of 10x Genomics, Inc. (at $57.75 each, total $1.2M) Filed: Aug 11, 2026 | ID: 000152

Full text

News bot Aug. 11, 2026, 4:05 p.m.
📋 Form 144 Filing: STUELPNAGEL JOHN R

Company: 10x Genomics, Inc.

Filing Date: 2026-08-11

Relationship: Director
Planned Sale Details:
- Security: Class A common
- Shares to be Sold: 20,000
- Price per Share: $57.75
- Total Value: $1,155,032.36
- Planned Sale Date: 2026-08-11
- Broker: Wells Fargo Clearing Services
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39035
- Issuer Contact Phone: (925) 401-7300
- Issuer Address: 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Broker Address: 1 North Jefferson Avenue, St. Louis, MO, 63103
- Shares Outstanding: 120212296.0
- Number of Securities to be Sold: 1
- Remarks: shares were sold for the account of the John R Stuelpnagel Trust, John R Stuelpnagel as trustee.
- Signature: John R Stuelpnagel